Genus PLC
1 March 2001
GENUS PLC ('GENUS')
TRADING UPDATE
The recent outbreak of foot and mouth disease and the resulting safety
precautions introduced to restrict the spread of the disease are having an
adverse effect on Genus' short-term trading. The severe limitations being
placed on farm access are restricting the company's ability to attend farms.
This is affecting the businesses of the Breeding Division, the Consulting
Division and the sector of the Distribution Division which provides services
to vets involved in the large animal sector.
As a result, turnover and income during the last week in February was well
below the Board's previous expectations and this downturn is expected to
continue throughout March. The overseas agricultural businesses have been
unaffected and continue to trade in line with expectations.
The Board is urgently reviewing how to adjust the cost base to mitigate the
impact on profits but confidently expects that trading should recover swiftly
as soon as the disease has been eradicated.
Once the extent of the outbreak can be quantified more accurately a further
announcement will be made.
Contact:
Richard Wood Genus plc Tel: 01270 536501
Giles Elliott Bridgewell Corporate Finance Tel: 020 7523 5803
Charles Ryland Buchanan Communications Tel: 020 7466 5000
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.